Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.10 | 11.11 |
| PEG Ratio (TTM) | 0.20 | -0.43 |
| P/S Ratio (TTM) | 0.98 | 2.83 |
| P/B Ratio (TTM) | 1.43 | 2.88 |
| P/FCF Ratio (TTM) | 14.41 | 13.25 |
| Price to 5YR AVG Earnings Ratio | 10.12 | 9.62 |
| Price to 5YR AVG FCF Ratio | 9.76 | 9.15 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.70% | 1.92% |
| ROE (TTM) | -14.60% | 11.59% |
| Net Profit Margin (TTM) | -10.91% | -123.72% |
| ROIC 5YR AVG | 22.78% | 22.33% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -172.40% | 38.40% | -14.29% |
| Revenue | -8.75% | 22.82% | 8.49% |
| Net Income | -170.65% | 38.37% | -14.42% |
| Cash Flow | -3.21% | 26.84% | 4.53% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.55 | 1.82 |
| Quick Ratio (TTM) | 0.52 | 0.87 |
| D/E Ratio (TTM) | 0.05 | 1.61 |
| Interest Coverage (TTM) | 5.09 | 14.46 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 3.42 | 2.76 |
| LTL to 5YR AVG FCF | N/A | 5.02 |
| Shares Outstanding Growth 5YR AVG | -0.38% | -1.96% |